Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Vivesto

7.22 SEK+5.87 %22/10 17:25
Less than 1K followers

VIVE

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
+5.87 %
-19.96 %
-17.77 %
-10.64 %
-38.55 %
-62.72 %
-60.59 %
-96.50 %
-99.54 %

Vivesto is a pharmaceutical company focused on developing innovative treatments for serious oncology diseases. The company is researching new therapies that can improve patient outcomes and quality of life. The company operates globally with a primary presence in Europe and North America. Vivesto was founded in 1988 and is headquartered in Uppsala, Sweden.

Read more
Market cap
79.94M SEK
Turnover
46.07K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
12/11
2026

Interim report Q3'26

11/2
2027

Annual report '26

All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-10-22 09:07

Finansinspektionen: Flaggningsmeddelande i Vivesto AB

Vivesto
Press release2026-10-19 09:30

Investor Studios: Vivesto diskuterar studieresultat och nästa steg för Paccal Vet

Vivesto
Regulatory press release2026-10-14 09:38

Finansinspektionen: Flaggningsmeddelande i Vivesto AB

Vivesto

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-10-13 13:47

DNB Carnegie Access: Vivesto: Key congress exposure for Paccal Vet data

Vivesto
Press release2026-10-13 08:00

Vivesto presenterar Paccal Vet-data vid WSAVA World Congress 2026

Vivesto
Press release2026-10-13 08:00

Vivesto presents Paccal Vet data at the WSAVA World Congress 2026

Vivesto
Press release2026-09-24 08:00

Vivesto presenterar data för Paccal Vet vid Veterinary Cancer Society Annual Conference 2026

Vivesto
Press release2026-09-24 08:00

Vivesto presents Paccal Vet data at the Veterinary Cancer Society Annual Conference 2026

Vivesto
Press release2026-09-21 17:28

DNB Carnegie Access: Vivesto - Framsteg inom veterinärmedicin

Vivesto
Press release2026-09-17 11:35

DNB Carnegie Access: Vivesto: Positive top-line results in cat study

Vivesto
Regulatory press release2026-09-17 10:08

Vivesto rapporterar positiva topline-resultat från Paccal Vet-studien i katt som stödjer fortsatt klinisk utveckling

Vivesto
Regulatory press release2026-09-17 10:08

Vivesto reports positive Paccal Vet cat topline results supporting continued clinical development

Vivesto
Press release2026-09-15 15:53

DNB Carnegie Access: Vivesto: Positive top-line results in dog study

Vivesto
Regulatory press release2026-09-15 13:45

Positiva topline-resultat i Vivestos pilotstudie i hund stödjer fortsatt utveckling och stärker partnerskapsmöjligheterna för Paccal Vet

Vivesto
Regulatory press release2026-09-15 13:45

Vivesto’s positive dog topline results support continued development and strengthen partnering prospects for Paccal Vet

Vivesto
Press release2026-08-13 18:48

DNB Carnegie Access: Vivesto: Largely a non-event, key readouts ahead – Q2 review

Vivesto
Regulatory press release2026-08-13 08:00

Delårsrapport för perioden 1 januari – 30 juni 2026

Vivesto
Regulatory press release2026-08-10 10:53

Finansinspektionen: Flaggningsmeddelande i Vivesto AB

Vivesto
Press release2026-07-01 10:04

DNB Carnegie Access: Vivesto: Cat study enrolment completed, results expected in Q4

Vivesto
Press release2026-07-01 08:00

Vivesto slutför rekryteringen i studie med Paccal Vet i katter och fastställer maximalt tolererbar dos

Vivesto